15.08.2023 12:24:00

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRHC, DBTX, VRTV, ZYNE

NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC (PRNewsfoto/Halper Sadeh LLP)

Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)'s sale to Nautic Partners for $10.50 in cash per share. If you are a Tabula Rasa shareholder, click here to learn more about your rights and options.

Decibel Therapeutics, Inc. (NASDAQ: DBTX)'s sale to Regeneron Pharmaceuticals, Inc. Under the terms of the merger, Decibel shareholders will receive $4.00 per share in cash and a non-tradeable contingent value right entitling such holders to receive up to $3.50 per share in cash if certain clinical development and regulatory milestones are achieved. If you are a Decibel shareholder, click here to learn more about your rights and options.

Veritiv Corporation (NYSE: VRTV)'s sale to an affiliate of Clayton, Dubilier & Rice, LLC for $170.00 per share in cash. If you are a Veritiv shareholder, click here to learn more about your rights and options.

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE)'s sale to Harmony Biosciences Holdings, Inc. Under the terms of the agreement, Harmony would acquire all outstanding shares of Zynerba for $1.1059 per share in cash, plus one non-tradeable contingent value right per share, representing the right to receive potential additional payments of up to $140 million in the aggregate, subject to the achievement of certain clinical, regulatory and sales milestones. If you are a Zynerba shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-trhc-dbtx-vrtv-zyne-301900782.html

SOURCE Halper Sadeh LLP

Nachrichten zu Tabula Rasa HealthCare Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Tabula Rasa HealthCare Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!